Burjeel lists inaugural $500m sukuk in London
The issuance also represents the first sukuk by a MENA healthcare provider since 2018
13 July, 2026
TT
16
Burjeel Holdings has marked the admission of its inaugural $500m sukuk to trading on the London Stock Exchange’s International Securities Market (ISM), celebrating the milestone with a Market Open Ceremony that underscores the healthcare group’s entry into the international debt capital markets.
The ceremony was attended by Sheikh Khalid bin Saud Al Qasimi, Deputy Chief of Mission at the UAE Embassy in the UK, Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, alongside senior executives from Burjeel Holdings and representatives of the London Stock Exchange.
The listing follows the successful issuance of Burjeel’s inaugural sukuk under its $1.5bn Senior Unsecured Sukuk Programme, marking the group’s first international debt capital markets transaction.
The issuance also represents the first sukuk by a MENA healthcare provider since 2018, highlighting renewed investor interest in the region’s healthcare sector.
The proceeds will be used to refinance existing debt while supporting Burjeel Holdings’ long-term growth strategy, including investments in specialised clinical services, research, medical education, digital transformation and artificial intelligence-enabled healthcare.
Dr. Shamsheer Vayalil, chairman and CEO of Burjeel Holdings, said: “Today’s ceremony marks an important chapter in Burjeel Holdings’ journey. It reflects how far we have come as an organization and reinforces our commitment to building a healthcare platform that combines clinical excellence with long-term financial strength. As we continue to grow across the region, this milestone provides a stronger foundation to invest in our people, expand specialized healthcare services, and advance research, education and innovation for the benefit of the communities we serve.”
Investor demand for the sukuk was strong, with the offering attracting a $1.6bn orderbook, equivalent to 3.2 times oversubscription. International investors accounted for 61 per cent of the final allocation, reflecting broad global participation.
The sukuk received investment-grade credit assessments of BB+ from S&P Global Ratings and Ba2 from Moody’s Ratings, supporting Burjeel’s objective of diversifying its funding sources while strengthening its financial position.
The successful listing further enhances Burjeel Holdings’ access to international capital markets as the Abu Dhabi-headquartered healthcare group continues expanding its regional footprint and investing in next-generation healthcare infrastructure and innovation.





















